University of Colorado Anschutz Medical Campus
ORCID: 0000-0002-6339-3820Pilot corpus only
This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.
Driven by 2 papers. Top paper: “The validation of new CHD1L inhibitors as a therapeutic strategy for cancer”.
Paul Awolade, Qiong Zhou, Hector Esquer, Brock Matter, J. Kearns +5 more
Brock Matter, Rachel R. Hartman, David W. A. Bourne, Yan Wang, Stephanie Choi +2 more